{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:10:00Z","timestamp":1790176200625,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.jinf.2010.02.009","type":"journal-article","created":{"date-parts":[[2010,2,21]],"date-time":"2010-02-21T04:28:54Z","timestamp":1266726534000},"page":"386-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Listeria endocarditis in a patient with psoriatic arthritis on infliximab: Are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?"],"prefix":"10.1016","volume":"60","author":[{"given":"Theodoros","family":"Kelesidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Salhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Fleisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Z.","family":"Uslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2010.02.009_bib1","unstructured":"http:\/\/www.fdable.com\/aers\/query\/972d415847bf\/7 [last visited 1\/20\/2010]. http:\/\/wwwfdablecom\/aers\/query\/972d415847bf\/7 [last visited 1\/20\/2010], 2010."},{"issue":"3","key":"10.1016\/j.jinf.2010.02.009_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2177\/jsci.29.160","article-title":"A case in which the subject was affected by Listeria meningoencephalitis during administration of infliximab for steroid-dependent adult onset Still's disease","volume":"29","author":"Yamamoto","year":"2006","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"issue":"5","key":"10.1016\/j.jinf.2010.02.009_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1155\/2005\/814698","article-title":"Listeria meningitis complicating infliximab treatment for Crohn's disease","volume":"16","author":"Williams","year":"2005","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"11","key":"10.1016\/j.jinf.2010.02.009_bib4","first-page":"829","article-title":"Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha","volume":"5","author":"Tweezer-Zaks","year":"2003","journal-title":"Isr Med Assoc J"},{"issue":"49","key":"10.1016\/j.jinf.2010.02.009_bib5","first-page":"3794","article-title":"Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports","volume":"102","author":"Soderlin","year":"2005","journal-title":"Lakartidningen"},{"issue":"1","key":"10.1016\/j.jinf.2010.02.009_bib6","first-page":"157","article-title":"Infliximab therapy in Crohn's disease complicated by Listeria monocytogenes meningoencephalitis","volume":"30","author":"Ramanampamonjy","year":"2006","journal-title":"Gastroenterol Clin Biol"},{"issue":"1","key":"10.1016\/j.jinf.2010.02.009_bib7","first-page":"60","article-title":"Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease","volume":"98","author":"Osuna","year":"2006","journal-title":"Rev Esp Enferm Dig"},{"issue":"3","key":"10.1016\/j.jinf.2010.02.009_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1572-0241.2000.01872.x","article-title":"Does administration of infliximab increase susceptibility to listeriosis?","volume":"95","author":"Morelli","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"43","key":"10.1016\/j.jinf.2010.02.009_bib9","first-page":"2145","article-title":"Meningitis due to Listeria monocytogenes as a complication of infliximab therapy","volume":"147","author":"Keulen","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"12","key":"10.1016\/j.jinf.2010.02.009_bib10","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s10067-007-0660-8","article-title":"Listeria infections associated with infliximab: case reports","volume":"26","author":"Kesteman","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.jinf.2010.02.009_bib11","first-page":"410","article-title":"Listeria meningitis after treatment with infliximab","volume":"34","author":"Kamath","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"30","key":"10.1016\/j.jinf.2010.02.009_bib12","first-page":"1470","article-title":"Meningitis due to Listeria monocytogenes as a complication of infliximab therapy","volume":"147","author":"Joosten","year":"2003","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"3","key":"10.1016\/j.jinf.2010.02.009_bib13","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ibd.20286","article-title":"Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease","volume":"14","author":"Izbeki","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"8","key":"10.1016\/j.jinf.2010.02.009_bib14","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1055\/s-2006-926670","article-title":"Listeria meningitis in a patient with Crohn's disease\u2013a seldom, but clinically relevant adverse event of therapy with infliximab","volume":"44","author":"Dederichs","year":"2006","journal-title":"Z Gastroenterol"},{"issue":"10","key":"10.1016\/j.jinf.2010.02.009_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1157\/13072579","article-title":"Sepsis caused by Listeria monocytogenes related with the use of infliximab","volume":"124","author":"de la Fuente","year":"2005","journal-title":"Med Clin (Barc)"},{"issue":"5","key":"10.1016\/j.jinf.2010.02.009_bib16","first-page":"250","article-title":"Lysteria encephalitis associated to infliximab administration","volume":"205","author":"Cabades","year":"2005","journal-title":"Rev Clin Esp"},{"issue":"1","key":"10.1016\/j.jinf.2010.02.009_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1345\/aph.1D151","article-title":"Listeria meningitis associated with infliximab","volume":"38","author":"Bowie","year":"2004","journal-title":"Ann Pharmacother"},{"issue":"6","key":"10.1016\/j.jinf.2010.02.009_bib18","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/art.11019","article-title":"Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Gluck et al","volume":"48","author":"Aparicio","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.jinf.2010.02.009_bib19","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/gut.2003.018515","article-title":"Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm county","volume":"53","author":"Ljung","year":"2004","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.jinf.2010.02.009_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/art.10758","article-title":"Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents","volume":"48","author":"Slifman","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.jinf.2010.02.009_bib21","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/art.10374","article-title":"Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases","volume":"46","author":"Gluck","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"9317","key":"10.1016\/j.jinf.2010.02.009_bib22","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jinf.2010.02.009_bib23","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0952-7915(00)00112-6","article-title":"Immunity to Listeria infection","volume":"12","author":"Edelson","year":"2000","journal-title":"Curr Opin Immunol"},{"issue":"3","key":"10.1016\/j.jinf.2010.02.009_bib24","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0092-8674(93)90134-C","article-title":"Mice deficient for the 55\u00a0kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection","volume":"73","author":"Pfeffer","year":"1993","journal-title":"Cell"},{"issue":"6440","key":"10.1016\/j.jinf.2010.02.009_bib25","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/364798a0","article-title":"Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes","volume":"364","author":"Rothe","year":"1993","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.jinf.2010.02.009_bib26","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1128\/IAI.70.9.4805-4811.2002","article-title":"Comparison of host resistance to primary and secondary Listeria monocytogenes infections in mice by intranasal and intravenous routes","volume":"70","author":"Mizuki","year":"2002","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.jinf.2010.02.009_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1128\/JB.00852-07","article-title":"The metalloprotease of Listeria monocytogenes is activated by intramolecular autocatalysis","volume":"190","author":"Bitar","year":"2008","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.jinf.2010.02.009_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2249.2005.02840.x","article-title":"The paradox of matrix metalloproteinases in infectious disease","volume":"142","author":"Elkington","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jinf.2010.02.009_bib29","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1740-2557-3-5","article-title":"Decreased levels of metalloproteinase-9 and angiogenic factors in skin lesions of patients with psoriatic arthritis after therapy with anti-TNF-alpha","volume":"3","author":"Cordiali-Fei","year":"2006","journal-title":"J Autoimmune Dis"},{"issue":"10","key":"10.1016\/j.jinf.2010.02.009_bib30","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/S1286-4579(00)01282-X","article-title":"The divergent role of tumor necrosis factor receptors in infectious diseases","volume":"2","author":"Schluter","year":"2000","journal-title":"Microbes Infect"},{"issue":"19","key":"10.1016\/j.jinf.2010.02.009_bib31","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.jinf.2010.02.009_bib32","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1086\/383317","article-title":"Granulomatous infectious diseases associated with tumor necrosis factor antagonists","volume":"38","author":"Wallis","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.jinf.2010.02.009_bib33","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1002\/art.21386","article-title":"Infections in patients with rheumatoid arthritis treated with biologic agents","volume":"52","author":"Listing","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.jinf.2010.02.009_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/rheumatology\/kel236","article-title":"Infections during tumour necrosis factor-alpha blocker therapy for rheumatic diseases in daily practice: a systematic retrospective study of 709 patients","volume":"46","author":"Salliot","year":"2007","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 3","key":"10.1016\/j.jinf.2010.02.009_bib35","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1136\/ard.2006.061937","article-title":"Updated consensus statement on biological agents for the treatment of rheumatic diseases","volume":"65","author":"Furst","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jinf.2010.02.009_bib36","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/rheumatology\/keg263","article-title":"Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy","volume":"42","author":"Kroesen","year":"2003","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.jinf.2010.02.009_bib37","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1093\/clinids\/12.5.820","article-title":"Listerial myocarditis in cardiac transplantation","volume":"12","author":"Stamm","year":"1990","journal-title":"Rev Infect Dis"},{"issue":"3\u20134","key":"10.1016\/j.jinf.2010.02.009_bib38","first-page":"197","article-title":"Fatal septicaemia due to Listeria monocytogenes in a patient with systemic lupus erythematosus receiving cyclosporin and high prednisone doses","volume":"40","author":"Giunta","year":"1992","journal-title":"Neth J Med"},{"issue":"6","key":"10.1016\/j.jinf.2010.02.009_bib39","first-page":"1238","article-title":"Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis","volume":"28","author":"Moreland","year":"2001","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.jinf.2010.02.009_bib40","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/ard.2003.013052","article-title":"Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed","volume":"63","author":"van de Putte","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.jinf.2010.02.009_bib41","first-page":"883","article-title":"Risks and benefits of tumor necrosis factor-alpha inhibitors in the management of psoriatic arthritis: systematic review and metaanalysis of randomized controlled trials","volume":"35","author":"Saad","year":"2008","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.jinf.2010.02.009_bib42","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jinf.2010.02.009_bib43","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/ard.2004.032268","article-title":"Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial","volume":"64","author":"Antoni","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jinf.2010.02.009_bib44","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/ard.2006.058339","article-title":"Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial","volume":"66","author":"Kavanaugh","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.jinf.2010.02.009_bib45","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/art.20967","article-title":"Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT)","volume":"52","author":"Antoni","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.jinf.2010.02.009_bib46","first-page":"869","article-title":"Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the infliximab multinational psoriatic arthritis controlled trial (IMPACT)","volume":"35","author":"Antoni","year":"2008","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.jinf.2010.02.009_bib47","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJM199603213341206","article-title":"Intracellular pathogenesis of listeriosis","volume":"334","author":"Southwick","year":"1996","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jinf.2010.02.009_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ijid.2003.06.002","article-title":"Prosthetic valve endocarditis due to Listeria monocytogenes. Report of two cases and reviews","volume":"8","author":"Fernandez Guerrero","year":"2004","journal-title":"Int J Infect Dis"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310000526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445310000526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:13:48Z","timestamp":1759007628000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445310000526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0163445310000526"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2010.02.009","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Listeria endocarditis in a patient with psoriatic arthritis on infliximab: Are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2010.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}